Journal ArticleDOI
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
Reads0
Chats0
About:
This article is published in European Heart Journal.The article was published on 1994-10-01. It has received 1177 citations till now. The article focuses on the topics: Framingham Risk Score.read more
Citations
More filters
Journal ArticleDOI
Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
Marjolein Geleedst-De Vooght,Anke-Hilse Maitland-van der Zee,Tom Schalekamp,Aukje K. Mantel-Teeuwisse,Paul A. F. Jansen +4 more
TL;DR: The beneficial effects of statins in the elderly observed in clinical trials may not be achieved in everyday practice, as the prevalence and incidence of statin use were lower in elderly patients compared with younger patients.
Journal ArticleDOI
Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.
Jutta Kuepper-Nybelen,Martin Hellmich,Sascha Abbas,Peter Ihle,Reinhard Griebenow,Ingrid Schubert +5 more
TL;DR: In everyday practice, post AMI patients benefit from guideline-oriented treatment, but the percentage of adherent patients should be improved.
Journal ArticleDOI
Marine n-3 fatty acids: basic features and background.
Erik Berg Schmidt,Jeppe Hagstrup Christensen,Inge Valbak Aardestrup,Trine Madsen,Sam Riahi,Vibeke Ellegaard Hansen,Helle Aarup Skou +6 more
TL;DR: It is puzzling, however, that a very low amount of n-3 PUFA, with no known beneficial biochemical effects, seems to be cardioprotective, and it has been of paramount interest to perform clinical trials and the results have been very encouraging.
Journal ArticleDOI
Effects of Policosanol on Older Patients with Hypertension and Type II Hypercholesterolaemia
TL;DR: Policosanol administered long term is effective in lowering LDL-C and TC as well as increasing HDL-C levels in older patients with hypertension and type II hypercholesterolaemia without a history of CHD or cerebrovascular disease.
Journal ArticleDOI
Pericardial disease: what the general cardiologist needs to know
TL;DR: The pertinent features of the major pericardial diseases seen in clinical practice and the recommended diagnostic and treatment strategies are focused on.
Related Papers (5)
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more